ADARx Pharmaceuticals Further Expands Leadership Team, Appointing Feriandas Greblikas, M.D. as VP of Clinical Development
Copyright 2022, Business Wire.
news
2022-10-18 13:46:00

October 18, 2022 09:46 AM Eastern Daylight Time SAN DIEGO--(BUSINESS WIRE)--ADARx Pharmaceuticals, Inc., a biotechnology company developing RNA-targeting therapeutics, today announced the further expansion of their leadership team and clinical development capabilities through the appointment of Feriandas Greblikas, M.D. as Vice President of Clinical Development.



'We are very excited to have Feriandas join the ADARx team,' said Dr. Zhen Li, President and Chief Executive officer of ADARx. 'With his wealth of experience in drug development and clinical execution, he will make significant contributions to ADARx's strategy, and operational effectiveness as we continue to advance programs to the clinic.
